Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$16,550,716
+$621,051 QoQ
Shares Held
65,168
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#835
of 4,676 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $978,265,315 across 7 Drug Manufacturers - General names. JNJ ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,279,269 | $242,574,987 | |
| 2 | PFE |
Pfizer Inc
|
7,612,597 | $183,311,335 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
3,053,480 | $175,941,517 | |
| 4 | BIIB |
Biogen Inc.
|
570,974 | $123,364,642 | |
| 5 | ABBV |
AbbVie Inc.
|
482,591 | $121,439,199 | |
| 6 | LLY |
ELI LILLY & Co
|
95,948 | $115,082,919 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
65,168 | $16,550,716 |
All Filings in JNJ
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,550,716 | 65,168 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $15,929,665 | 65,168 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $11,622,932 | 56,163 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $5,923,612 | 31,947 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,637,490 | 30,360 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,034,902 | 30,360 | Shares | Sole | 2025-04-24 | |
| 2024-03-31 | $8,587,344 | 54,285 | Shares | Sole | 2024-04-16 | |
| 2023-06-30 | $45,367,542 | 274,091 | Shares | Sole | 2023-07-19 | |
| 2022-03-31 | $13,436,515 | 75,814 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $22,411,839 | 138,773 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $21,450,465 | 130,208 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $37,806,580 | 230,037 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $28,706,426 | 182,402 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $105,135,185 | 706,174 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $102,867,188 | 731,474 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $106,457,890 | 811,850 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||